15Mar
24Jan
Myomo Inc. among recipients of grants from Philadelphia Pediatric Medical Device Consortium
The Philadelphia Pediatric Medical Device Consortium, based out of the Children’s Hospital of Philadelphia, has announced seed grants of $50,000 each to three companies to develop medical devices for children. One of these companies is Myomo Inc. Read more >>
07Jan
Ottobock Signs Distribution Agreement With Myomo
Ottobock, a market leader in technical orthopedics, and Myomo, Inc., a manufacturer of myoelectric orthotics, have reached an agreement for Ottobock to exclusively distribute the Myomo patented MyoPro orthosis technology globally, starting with select markets in North America and Germany. Read more >>
30Nov
Myomo Inc. to Present at the 9th Annual LD Micro Main Event
Myomo, Inc., a commercial-stage medical robotics company whose products enable users to overcome upper extremity paralysis (www.myomo.com), today announced that Chief Executive Officer, Paul Gudonis, is scheduled to present at the 9th Annual LD Micro Main Event. Read more >>
23Nov
Myomo Wants to Help Brain Injury Survivors Overcome Paralysis
For those who experience a stroke or traumatic brain injury, some are left with having to cope and adapt to having a paralyzed or weak limb. According to Cleveland Clinic, patients who have a left-brain stroke may experience paralysis on the right side of their body. Also, as stated by the National Stroke Association, as many as 9 out of 10 stroke survivors have some degree of paralysis immediately following a stroke. Myomo, a medtech company, is working to empower...
22Nov
Myomo Announces Planned IPO
Myomo, a medical robotics company, has submitted a Form 1-A with the Securities and Exchange Commission regarding its proposes initial public offering on the NYSE. Read more >>
22Nov
Medical Robotics Firm Myomo Explores Going Public
Myomo, Inc., a commercial-stage medical robotics company whose products enable users to overcome upper extremity paralysis (www.myomo.com), announced today that it has confidentially submitted a Form 1-A with the Securities and Exchange Commission (SEC) relating to the proposed initial public offering of its common stock under the recently amended provisions of Regulation A pursuant to the Jumpstart Our Business Startups (JOBS) Act of 2012. The number of shares to be offered and the price range for the proposed offering have...
19Nov
Medical robotics firm treating upper extremity paralysis explores going public
Cambridge, Massachusetts-based Myomo announced Friday that it is taking advantage of new SEC provisions that allow early-stage companies to raise capital without restricting it to only accredited investors Through the Regulation A+ provision, which is an amendment to Regulation A, the Securities & Exchange Commission adopted rules that went into effect June 2015 allowing early-stage companies to raise a maximum of $50 million from the public. They are known as mini-IPOs and mark a pivotal moment given the agency accepted equity crowdfunding...
19Nov
Myomo Files for Reg A+ Offer. Expects to List on NYSE Following Funding Round
Myomo, a medical robotics company whose products enable users to overcome upper extremity paralysis, has filed a Form 1-A with the SEC indicating its intent to raise money under Reg A+, a crowdfunding exemption that allows issuers to seek up to $50 million in capital. Read more >>
19Nov